Emily C. Carroll
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Mutant TDP-43 drives impairments in axonal transport and glycolysis in a mouse stem-cell-derived motor neuron model of amyotrophic lateral sclerosis (ALS).
Journal: Cell death & disease
Published: July 02, 2025
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Journal: Expert opinion on drug discovery
Published: March 03, 2025
Recent developments in gene therapy for Parkinson's disease.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 31, 2025
Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons.
Journal: Brain communications
Published: February 13, 2024
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9.
Journal: Nature communications
Published: February 09, 2023
Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis.
Journal: EBioMedicine
Published: April 21, 2022
Type 2 diabetes is associated with the accumulation of senescent T cells.
Journal: Clinical and experimental immunology
Published: June 25, 2019
Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis.
Journal: Acta neuropathologica
Published: November 16, 2017
Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids.
Journal: European journal of pain (London, England)
Published: January 30, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026